Stay updated on Immunostrategies in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunostrategies in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trial page.

Latest updates to the Immunostrategies in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference5%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check111 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference5%
Stay in the know with updates to Immunostrategies in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunostrategies in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trial page.